283 related articles for article (PubMed ID: 19276382)
1. RasV12-mediated down-regulation of CCAAT/enhancer binding protein beta in immortalized fibroblasts requires loss of p19Arf and facilitates bypass of oncogene-induced senescence.
Sebastian T; Johnson PF
Cancer Res; 2009 Mar; 69(6):2588-98. PubMed ID: 19276382
[TBL] [Abstract][Full Text] [Related]
2. An Arf-Egr-C/EBPβ pathway linked to ras-induced senescence and cancer.
Salotti J; Sakchaisri K; Tourtellotte WG; Johnson PF
Mol Cell Biol; 2015 Mar; 35(5):866-83. PubMed ID: 25535333
[TBL] [Abstract][Full Text] [Related]
3. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
Shin J; Yang J; Lee JC; Baek KH
Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
[TBL] [Abstract][Full Text] [Related]
4. C/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence.
Sebastian T; Malik R; Thomas S; Sage J; Johnson PF
EMBO J; 2005 Sep; 24(18):3301-12. PubMed ID: 16107878
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle-dependent phosphorylation of C/EBPbeta mediates oncogenic cooperativity between C/EBPbeta and H-RasV12.
Shuman JD; Sebastian T; Kaldis P; Copeland TD; Zhu S; Smart RC; Johnson PF
Mol Cell Biol; 2004 Sep; 24(17):7380-91. PubMed ID: 15314150
[TBL] [Abstract][Full Text] [Related]
6. The molecular scaffold kinase suppressor of Ras 1 is a modifier of RasV12-induced and replicative senescence.
Kortum RL; Johnson HJ; Costanzo DL; Volle DJ; Razidlo GL; Fusello AM; Shaw AS; Lewis RE
Mol Cell Biol; 2006 Mar; 26(6):2202-14. PubMed ID: 16507997
[TBL] [Abstract][Full Text] [Related]
7. C/EBPbeta represses p53 to promote cell survival downstream of DNA damage independent of oncogenic Ras and p19(Arf).
Ewing SJ; Zhu S; Zhu F; House JS; Smart RC
Cell Death Differ; 2008 Nov; 15(11):1734-44. PubMed ID: 18636078
[TBL] [Abstract][Full Text] [Related]
8. E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest.
Rowland BD; Denissov SG; Douma S; Stunnenberg HG; Bernards R; Peeper DS
Cancer Cell; 2002 Jul; 2(1):55-65. PubMed ID: 12150825
[TBL] [Abstract][Full Text] [Related]
9. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence.
Zou X; Ray D; Aziyu A; Christov K; Boiko AD; Gudkov AV; Kiyokawa H
Genes Dev; 2002 Nov; 16(22):2923-34. PubMed ID: 12435633
[TBL] [Abstract][Full Text] [Related]
10. C/EBPγ suppresses senescence and inflammatory gene expression by heterodimerizing with C/EBPβ.
Huggins CJ; Malik R; Lee S; Salotti J; Thomas S; Martin N; Quiñones OA; Alvord WG; Olanich ME; Keller JR; Johnson PF
Mol Cell Biol; 2013 Aug; 33(16):3242-58. PubMed ID: 23775115
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic Ras induces p19ARF and growth arrest in mouse embryo fibroblasts lacking p21Cip1 and p27Kip1 without activating cyclin D-dependent kinases.
Groth A; Weber JD; Willumsen BM; Sherr CJ; Roussel MF
J Biol Chem; 2000 Sep; 275(35):27473-80. PubMed ID: 10842176
[TBL] [Abstract][Full Text] [Related]
12. C/EBPβ deletion in oncogenic Ras skin tumors is a synthetic lethal event.
Messenger ZJ; Hall JR; Jima DD; House JS; Tam HW; Tokarz DA; Smart RC
Cell Death Dis; 2018 Oct; 9(11):1054. PubMed ID: 30323292
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic ras and p53 cooperate to induce cellular senescence.
Ferbeyre G; de Stanchina E; Lin AW; Querido E; McCurrach ME; Hannon GJ; Lowe SW
Mol Cell Biol; 2002 May; 22(10):3497-508. PubMed ID: 11971980
[TBL] [Abstract][Full Text] [Related]
14. ELF4/MEF activates MDM2 expression and blocks oncogene-induced p16 activation to promote transformation.
Sashida G; Liu Y; Elf S; Miyata Y; Ohyashiki K; Izumi M; Menendez S; Nimer SD
Mol Cell Biol; 2009 Jul; 29(13):3687-99. PubMed ID: 19380490
[TBL] [Abstract][Full Text] [Related]
15. A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence.
Peeper DS; Shvarts A; Brummelkamp T; Douma S; Koh EY; Daley GQ; Bernards R
Nat Cell Biol; 2002 Feb; 4(2):148-53. PubMed ID: 11812999
[TBL] [Abstract][Full Text] [Related]
16. Ras-Raf-Arf signaling critically depends on the Dmp1 transcription factor.
Sreeramaneni R; Chaudhry A; McMahon M; Sherr CJ; Inoue K
Mol Cell Biol; 2005 Jan; 25(1):220-32. PubMed ID: 15601844
[TBL] [Abstract][Full Text] [Related]
17. The LIM-only protein FHL2 mediates ras-induced transformation through cyclin D1 and p53 pathways.
Labalette C; Nouët Y; Levillayer F; Armengol C; Renard CA; Soubigou G; Xia T; Buendia MA; Wei Y
PLoS One; 2008; 3(11):e3761. PubMed ID: 19018287
[TBL] [Abstract][Full Text] [Related]
18. A RAS-CaMKKβ-AMPKα2 pathway promotes senescence by licensing post-translational activation of C/EBPβ through a novel 3'UTR mechanism.
Basu SK; Gonit M; Salotti J; Chen J; Bhat A; Gorospe M; Viollet B; Claffey KP; Johnson PF
Oncogene; 2018 Jun; 37(26):3528-3548. PubMed ID: 29563610
[TBL] [Abstract][Full Text] [Related]
19. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
[TBL] [Abstract][Full Text] [Related]
20. AP4 directly downregulates p16 and p21 to suppress senescence and mediate transformation.
Jackstadt R; Jung P; Hermeking H
Cell Death Dis; 2013 Aug; 4(8):e775. PubMed ID: 23949224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]